About
RNA Delivery, Small Molecule
Areas of Focus
Categories
DiagnosticsSmall Molecule PharmaceuticalGene Therapy, RNA & Peptide TherapyDrug Delivery & FormulationBoston & New England
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
17
By Phase
PHASE1/PHASE2: 1EARLY_PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06260774Lead Sponsor
Study of TTX-MC138 in Subjects With Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Sep 5, 2024 · Completed: Feb 1, 2027
NCT05908773Lead Sponsor
A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors
EARLY_PHASE1Completed
1 participants
Started: Apr 4, 2023 · Completed: Sep 18, 2023
Locations (1)
Headquarters
Newton, MA, United States
Map
Loading map...